Effect of different doses of Vit. B12 on blood constituents and intestinal bacteria
Not Applicable
- Registration Number
- CTRI/2021/12/039018
- Lead Sponsor
- KEM Hospital Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Apparently healthy consenting participants
Completely COVID-19 vaccinated
Exclusion Criteria
Individuals taking / have taken B12 supplements over preceding 3 months.
Individuals taking H2 blockers, Proton Pump Inhibitors or those frequently using antacids, Metformin, chronic use of constipation treatment
Known patients of Pernicious Anaemia
Chronic pancreatitis, pancreatic insufficiency, malabsorption syndrome
Patients who have undergone surgical intestinal treatment
Pregnant women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method